Redox Limited (ASX: RDX) is pleased to announce that Redox has been selected for inclusion in the Standard & Poor’s (“S&P”)/ASX 300 Index by the S&P Dow Jones effective prior to ASX market opening on March 18, 2024.
Raimond Coneliano, CEO and Managing Director, comments, “We are very pleased that Redox has been selected for inclusion in the S&P/ASX 300 Index. This was one of our aspirations during our IPO process last year and we’re satisfied to have achieved this milestone so quickly. In a way, this is recognition of the enduring value that the company has built over nearly sixty years as a leading chemical and ingredients distributor coupled with an exciting growth trajectory as we expand globally. S&P/ASX 300 Index inclusion places Redox amongst the 300 largest securities traded on the ASX. It should help increase Redox’s trading liquidity through incremental demand for our shares from institutional investors and fund managers who track the composition of the Index and benchmark their performance against it.”
The S&P/ASX 300 is designed to provide investors with broader exposure to the Australian equity market. The index measures 300 of Australia’s largest highly liquid securities listed on the ASX by float-adjusted market capitalization. The S&P/ASX 300 index covers the large-cap, mid-cap, and small-cap components of the S&P/ASX Index Series.
This index is designed to provide investors with broad exposure to the Australian equity market while allowing them to benchmark against a wide selection of opportunities based on specific size and liquidity parameters.